Search research articles
Contact Us
Filters
Showing results (41-50 of 80) with videos related to
Page
of 8
Sort By:
Journal of Neurochemistry
|
April 1, 1982
High-affinity binding of [3H]desipramine to rat brain: a presynaptic marker for noradrenergic uptake sites
M Rehavi, P Skolnick, M J Brownstein, et al.
Biochemical Pharmacology
|
January 1, 1978
In vivo and in vitro studies on the antimuscarinic activity of some amino esters of benzilic acid
M Rehavi, B Yaavetz, Y Kloog, et al.
Psychiatry Research
|
September 1, 1984
High-affinity 3H-imipramine binding in platelets of children and adolescents with major affective disorders
M Rehavi, R Weizman, C Carel, et al.
Psychopharmacology
|
November 1, 1995
Alterations in hippocampal hemicholinium-3 binding and related behavioural and biochemical changes after prenatal phenobarbitone exposure
E H Zahalka, M Rehavi, M E Newman, et al.
Neuropsychobiology
|
January 1, 1988
Unaltered platelet [3H]-imipramine binding in dementia of the Alzheimer type
R Weizman, J Dick, A Mosek, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
July 21, 2006
Elevated platelet vesicular monoamine transporter 2 in former heroin addicts maintained on methadone
K Schwartz, I Herman, G Peer, et al.
Life Sciences
|
February 7, 1983
[3H]2-Nitroimipramine: a selective "slowly-dissociating" probe of the imipramine binding site ("serotonin transporter") in platelets and brain
M Rehavi, H Tracer, K Rice, et al.
Life Sciences
|
May 4, 1987
A comparative study of the affinities of some tricyclic antidepressants for the muscarinic cholinergic receptor in human and guinea-pig bladder, ileum and brain in relation to differential drug potency
M Rehavi, H Weiss, I Nissenkorn, et al.
Life Sciences
|
March 24, 1980
Demonstration of specific "high affinity" binding sites for [3H] imipramine on human platelets
S M Paul, M Rehavi, P Skolnick, et al.
Clinical Neuropharmacology
|
June 1, 1997
Significant inhibition of spontaneous IgA secretion by selective peripheral-type benzodiazepine receptor ligands
H Bessler, B Caspi, M Gavish, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 80) with videos related to
Sort By:
Page
of 8
Journal of Neurochemistry
|
April 1, 1982
High-affinity binding of [3H]desipramine to rat brain: a presynaptic marker for noradrenergic uptake sites
M Rehavi, P Skolnick, M J Brownstein, et al.
Biochemical Pharmacology
|
January 1, 1978
In vivo and in vitro studies on the antimuscarinic activity of some amino esters of benzilic acid
M Rehavi, B Yaavetz, Y Kloog, et al.
Psychiatry Research
|
September 1, 1984
High-affinity 3H-imipramine binding in platelets of children and adolescents with major affective disorders
M Rehavi, R Weizman, C Carel, et al.
Psychopharmacology
|
November 1, 1995
Alterations in hippocampal hemicholinium-3 binding and related behavioural and biochemical changes after prenatal phenobarbitone exposure
E H Zahalka, M Rehavi, M E Newman, et al.
Neuropsychobiology
|
January 1, 1988
Unaltered platelet [3H]-imipramine binding in dementia of the Alzheimer type
R Weizman, J Dick, A Mosek, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
July 21, 2006
Elevated platelet vesicular monoamine transporter 2 in former heroin addicts maintained on methadone
K Schwartz, I Herman, G Peer, et al.
Life Sciences
|
February 7, 1983
[3H]2-Nitroimipramine: a selective "slowly-dissociating" probe of the imipramine binding site ("serotonin transporter") in platelets and brain
M Rehavi, H Tracer, K Rice, et al.
Life Sciences
|
May 4, 1987
A comparative study of the affinities of some tricyclic antidepressants for the muscarinic cholinergic receptor in human and guinea-pig bladder, ileum and brain in relation to differential drug potency
M Rehavi, H Weiss, I Nissenkorn, et al.
Life Sciences
|
March 24, 1980
Demonstration of specific "high affinity" binding sites for [3H] imipramine on human platelets
S M Paul, M Rehavi, P Skolnick, et al.
Clinical Neuropharmacology
|
June 1, 1997
Significant inhibition of spontaneous IgA secretion by selective peripheral-type benzodiazepine receptor ligands
H Bessler, B Caspi, M Gavish, et al.
Page
of 8